Two 59%+ winners, four above 25% in Aug – How this AI model keeps picking winners
RedHill Biopharma Ltd. (NASDAQ:RDHL) announced Thursday that it has been granted an extension by the Nasdaq Stock Market LLC to regain compliance with Nasdaq Listing Rule 5550(b), which requires listed companies to maintain a minimum stockholders’ equity of $2.5 million.
According to a statement based on a recent SEC filing, Nasdaq’s Listing Qualifications Department issued an extension letter on August 8, allowing RedHill Biopharma until October 13, 2025, to meet the equity requirement for continued listing on the exchange.
The company previously reported that it received a deficiency notice from Nasdaq on April 15, 2025, for failing to comply with the minimum stockholders’ equity rule. RedHill Biopharma submitted a plan to Nasdaq outlining steps to regain compliance, which led to the current extension.
If the company does not meet the compliance requirement by October 13, it may appeal any determination of non-compliance to a Nasdaq Hearings Panel. An accepted appeal could provide RedHill Biopharma with additional time to regain compliance.
This information is based on a press release statement included in the company’s recent SEC filing.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.